BiondVax Pharmaceuticals Ltd. Sponsored ADR
(NASDAQ : BVXV)

( )
BVXV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading BVXV News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
1.08%136.670.6%$738.52m
PFEPfizer Inc.
-0.21%33.550.8%$528.22m
MRKMerck & Co., Inc.
0.53%62.950.6%$488.44m
ABBVAbbVie, Inc.
1.72%74.022.1%$346.62m
BMYBristol-Myers Squibb Company
0.71%55.461.4%$334.82m
LLYEli Lilly and Company
0.59%84.731.0%$241.52m
NVSNovartis AG Sponsored ADR
0.46%85.420.2%$170.32m
AZNAstraZeneca PLC Sponsored ADR
0.91%33.911.3%$163.82m
GSKGlaxoSmithKline plc Sponsored ADR
0.81%42.770.2%$94.32m
SNYSanofi Sponsored ADR
2.76%48.100.2%$85.59m
NVONovo Nordisk A/S Sponsored ADR Class B
2.26%43.530.1%$63.72m
LCILannett Company, Inc.
0.58%21.7838.7%$9.18m
SCMPSucampo Pharmaceuticals, Inc. Class A
0.93%10.9014.4%$4.64m
AKTXAkari Therapeutics Plc Sponsored ADR
-5.08%4.672.2%$0.42m
EPIXESSA Pharma Inc
-17.97%0.250.0%$0.04m

Company Profile

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Ness Ziona, Israel.